FI942011L - Kiteytymisenestoaineita sisältäviä transdermaalisia terapeuttisia järjestelmiä - Google Patents

Kiteytymisenestoaineita sisältäviä transdermaalisia terapeuttisia järjestelmiä Download PDF

Info

Publication number
FI942011L
FI942011L FI942011A FI942011A FI942011L FI 942011 L FI942011 L FI 942011L FI 942011 A FI942011 A FI 942011A FI 942011 A FI942011 A FI 942011A FI 942011 L FI942011 L FI 942011L
Authority
FI
Finland
Prior art keywords
transdermal therapeutic
systems containing
containing anti
therapeutic systems
crystallization agents
Prior art date
Application number
FI942011A
Other languages
English (en)
Swedish (sv)
Other versions
FI110061B (fi
FI942011A0 (fi
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI942011L publication Critical patent/FI942011L/fi
Publication of FI942011A0 publication Critical patent/FI942011A0/fi
Application granted granted Critical
Publication of FI110061B publication Critical patent/FI110061B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI942011A 1991-10-31 1994-04-29 Menetelmä kiteytymisenestoainetta sisältävän transdermaalisen terapeuttisen järjestelmän valmistamiseksi FI110061B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4136057 1991-10-31
DE4210711 1992-03-27
DE4210711A DE4210711A1 (de) 1991-10-31 1992-03-27 Transdermale therapeutische systeme mit kristallisationsinhibitoren
PCT/EP1992/002478 WO1993008795A1 (de) 1991-10-31 1992-10-21 Transdermale therapeutische systeme mit kristallisationsinhibitoren
EP9202478 1992-10-21

Publications (3)

Publication Number Publication Date
FI942011L true FI942011L (fi) 1994-04-29
FI942011A0 FI942011A0 (fi) 1994-04-29
FI110061B FI110061B (fi) 2002-11-29

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942011A FI110061B (fi) 1991-10-31 1994-04-29 Menetelmä kiteytymisenestoainetta sisältävän transdermaalisen terapeuttisen järjestelmän valmistamiseksi

Country Status (14)

Country Link
EP (1) EP0610357B1 (fi)
JP (1) JP3526864B2 (fi)
AT (1) ATE158181T1 (fi)
AU (2) AU2895392A (fi)
CA (1) CA2120599C (fi)
DE (2) DE4210711A1 (fi)
DK (1) DK0610357T3 (fi)
ES (1) ES2106888T3 (fi)
FI (1) FI110061B (fi)
GR (1) GR3025237T3 (fi)
HU (1) HU227531B1 (fi)
NO (1) NO307644B1 (fi)
PT (1) PT101019B (fi)
WO (1) WO1993008795A1 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE69401945T3 (de) 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
DK0836506T4 (da) † 1995-06-07 2012-01-30 Ortho Mcneil Pharm Inc Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19829713C1 (de) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutisches System mit Zusatz von Perglanzpigmenten
DE19834006A1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19843027A1 (de) * 1998-09-19 2000-03-23 Labtec Gmbh Neohesperidin DC als Kristallisationsinhibitor
AU779523B2 (en) * 1999-11-29 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic systems with improved stability and a method for the production thereof
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
JP4914826B2 (ja) 2005-02-28 2012-04-11 久光製薬株式会社 経皮吸収製剤
JP5546013B2 (ja) 2008-02-27 2014-07-09 久光製薬株式会社 貼付剤及び包装体
JP5485135B2 (ja) 2008-02-27 2014-05-07 久光製薬株式会社 貼付製剤
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
EP3824883B1 (en) * 2013-09-11 2023-08-02 MEDRx Co., Ltd. Novel composition for plaster base material in tape preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Also Published As

Publication number Publication date
AU1652997A (en) 1997-05-29
AU712692B2 (en) 1999-11-11
DE4210711A1 (de) 1993-05-06
CA2120599A1 (en) 1993-05-13
FI110061B (fi) 2002-11-29
EP0610357B1 (de) 1997-09-17
PT101019B (pt) 1999-10-29
DE59208918D1 (de) 1997-10-23
EP0610357A1 (de) 1994-08-17
CA2120599C (en) 2003-04-15
HU9401257D0 (en) 1994-08-29
WO1993008795A1 (de) 1993-05-13
ES2106888T3 (es) 1997-11-16
PT101019A (pt) 1994-02-28
JPH07506083A (ja) 1995-07-06
JP3526864B2 (ja) 2004-05-17
NO307644B1 (no) 2000-05-08
AU2895392A (en) 1993-06-07
NO941593L (no) 1994-04-29
HUT72964A (en) 1996-06-28
FI942011A0 (fi) 1994-04-29
NO941593D0 (fi) 1994-04-29
GR3025237T3 (en) 1998-02-27
HU227531B1 (en) 2011-07-28
DK0610357T3 (da) 1998-05-11
ATE158181T1 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
FI942011L (fi) Kiteytymisenestoaineita sisältäviä transdermaalisia terapeuttisia järjestelmiä
FI923379L (fi) Terapeutiska amider
FI935878L (fi) Porfycenfoereningar foer fotodynamisk terapi
FI943018A7 (fi) Terapeuttisia aineita
DE69307109D1 (de) Kathetervorrichtung
FI934964L (fi) Teraupetiskt aemne
IT228452Y1 (it) Dispositivo massaggiatore
DE69210290D1 (de) Behandlungsvorrichtung
DE69218932D1 (de) Transdermale therapeutische Formulierung
DK0609594T3 (da) Elektroterapiindretning
FI952204A7 (fi) Terapeuttisia aineita
FI943019A7 (fi) Terapeuttisia aineita
FI934189A7 (fi) Transdermalt terapeutiskt plaoster
DK0507513T3 (da) Terapeutisk anordning
FI950545L (fi) Käsittelylaite
FI924744L (fi) Terapeutiska aemnen
FI923663A7 (fi) Terapeutiska foereningar
FI962220L (fi) Transdermaalinen terapeuttinen järjestelmä
FI943020A7 (fi) Terapeuttisia aineita
FI923759L (fi) Terapeutiska bensazapinfoereningar
FI930674A7 (fi) Terapeuttiset aineet
PT100435A (pt) Nucleosidos terapeuticos
FI923662A7 (fi) Terapeuttisia aineita
AT397763B (de) Massageeinrichtung
DE69330817D1 (de) Heilvorrichtung

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

MA Patent expired